Trial design {8}
HNC
This exploratory study is multicentre and will be conducted at the Jules Bordet Institute and the Antwerp University Hospital, both located in Belgium. All measurements will be carried out once, in a single session per subject. HNC patients will be eligible for 3 months post-oncological treatment.